Assignee
THINK THERAPEUTICS INC
US·14 granted patents·11 pending applications·61 citations·filing 2020–2025
Top patents by PatentIndex Score
25 records- 0198US11058751B1Compositions for optimized RAS peptide vaccinesTHINK THERAPEUTICS INC·Filed 2020·Granted Jul 13, 2021·14 cites·30 claims
- 0297US11672850B2Compositions and method for optimized peptide vaccines using residue optimizationTHINK THERAPEUTICS INC·Filed 2022·Granted Jun 13, 2023·7 cites·30 claims
- 0397US11464842B1Compositions and method for optimized peptide vaccines using residue optimizationTHINK THERAPEUTICS INC·Filed 2021·Granted Oct 11, 2022·9 cites·8 claims
- 0497US11235039B1Immunogenic compositions comprising nucleic acids for RAS peptidesTHINK THERAPEUTICS INC·Filed 2021·Granted Feb 1, 2022·10 cites·30 claims
- 0597US11161892B1Method of compact peptide vaccines using residue optimizationTHINK THERAPEUTICS INC·Filed 2020·Granted Nov 2, 2021·12 cites·30 claims
- 0696US11673936B2Method of compact peptide vaccines using residue optimizationTHINK THERAPEUTICS INC·Filed 2022·Granted Jun 13, 2023·2 cites·30 claims
- 0795US11464837B2Immunogenic compositions comprising nucleic acids for RAS peptidesTHINK THERAPEUTICS INC·Filed 2021·Granted Oct 11, 2022·2 cites·18 claims
- 0895US11421015B2Method of compact peptide vaccines using residue optimizationTHINK THERAPEUTICS INC·Filed 2021·Granted Aug 23, 2022·2 cites·30 claims
- 0993US11111489B1Multiplexed testing of lymphocytes for antigen specificityTHINK THERAPEUTICS INC·Filed 2021·Granted Sep 7, 2021·3 cites·15 claims
- 1085US2024383963A1Method of compact peptide vaccines using residue optimizationTHINK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1184US12064475B2Compositions and method for optimized peptide vaccines using residue optimizationTHINK THERAPEUTICS INC·Filed 2023·Granted Aug 20, 2024·0 cites·30 claims
- 1284US2026000743A1Immunogenic compositions comprising nucleic acids for ras peptidesTHINK THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1383US2025213643A1Compositions and method for optimized peptide vaccines using residue optimizationTHINK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1482US12364741B2Immunogenic compositions comprising nucleic acids for RAS peptides and their use for treating cancerTHINK THERAPEUTICS INC·Filed 2022·Granted Jul 22, 2025·0 cites·14 claims
- 1581US12091443B2Method of compact peptide vaccines using residue optimizationTHINK THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·0 cites·15 claims
- 1677US12290554B2Compositions for optimized BCR-ABL peptide vaccinesTHINK THERAPEUTICS INC·Filed 2022·Granted May 6, 2025·0 cites·16 claims
- 1770US2026018250A1Computational generation of artificial proteins with programmable immunogenicityTHINK THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1867US2024269250A1Compositions and method for optimized peptide vaccines using residue optimizationTHINK THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1966US2026041763A1Compositions and methods for optimized covid peptide vaccinesTHINK THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2065US2025222087A1Compositions for optimized bcr-abl peptide vaccinesTHINK THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2164US2023126286A1Multiplexed testing of lymphocytes for antigen specificityTHINK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2264US2025333448A1Compositions for optimized influenza peptide vaccinesTHINK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2362US2024131133A1Compositions and methods for optimized kras peptide vaccinesTHINK THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2460US12486501B2Multiplexed testing of lymphocytes for antigen specificityTHINK THERAPEUTICS INC·Filed 2021·Granted Dec 2, 2025·0 cites·15 claims
- 2546US2025235526A1Compositions and methods for optimized hiv peptide vaccinesTHINK THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when THINK THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →